GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
105 hedge funds and large institutions have $355M invested in GenMark Diagnostics, Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
105
Holders Change
+7
Holders Change %
+7.14%
% of All Funds
2.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
37
Reduced
24
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$4.34M |
| 2 |
BlackRock
New York
|
+$1.6M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.21M |
| 4 |
Morgan Stanley
New York
|
+$1.15M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.12M |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.53M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$3.58M |
| 3 |
JPMorgan Chase & Co
New York
|
-$3.35M |
| 4 |
CC
Casdin Capital
New York
|
-$2.87M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.63M |
